Targeting the PTHrP?PTHR1?CREB axis as a therapeutic approach in osteosarcoma

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

We are interested in understanding how an important pathway in normal bone cells is functioning in osteosarcoma, the most common type of bone cancer.

Funded Activity Details

Start Date: 01-01-2015

End Date: 01-01-2017

Funding Scheme: Project Grants

Funding Amount: $668,823.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Solid Tumours

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

bone cancer | cancer cell biology | osteosarcoma | parathyroid hormone | parathyroid hormone-related protein (PTHrP)